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The high incidence and mortality of solid tumors like breast cancer makes the 
development of novel therapeutic agents a high priority. Curcumin, a natural substance 
from the rhizome of Curcuma longa, has captured the attention of the scientific 
community. Pre-clinical trials and extensive research has demonstrated its ability to 
prevent cancer. Indeed, curcumin has been shown to target critical genes involved in 
angiogenesis, apoptosis, cell cycle and metastasis, and consequently to inhibit cell 
growth. Currently, the clinical use of curcumin is mainly limited by its poor bioavailability 
which implies repetitive oral doses in order to achieve the therapeutic concentrations 
inside the cell. The idea of the present work is to design a strategy that could link the 
common technique used to treat solid tumors (ultrasound) with the therapeutic effects of 
curcumin. The plan is to use the temperature increase (consequence of ultrasound 
treatment) to trigger the in situ expression of curcumin by engineered bacteria. 
Escherichia coli was chosen as the model organism in which the genes involved in the 
curcumin pathway will be cloned. 
Those genes (4-coumarate: CoA ligase, diketide-CoA synthase and curcumin 
synthase) were successfully cloned under the control of a temperature sensitive promoter 
(dnaK). The proof-of-concept that the dnaK promoter can be induced by a temperature 
increase, leading to the expression of the 3 necessary genes, is currently being tested, 
using several biochemical assays. 
Moreover, several knockouts (KO) of specific genes from the E. coli K-12 MG1655 
genome were performed in order to maximize the production of curcumin. The deletion 
strategy, as well as the definition of the non-essential genes to be KO, was determined in 
silico. This strategy included one single KO (gnd gene) and the multiple KO of five non-
essential genes for aerobic growth (fumA, fumB, fumC, ccmA and argO) and serA gene 
for anaerobic growth. After optimizing the genes expression under the control of the 
temperature inducible promoter, the several KO will be transformed with this construction 
to confirm the improvement of curcumin production. 
  
Acknowledgments: This work was supported by Fundação para a Ciência e a Tecnologia (project 
PTDC/EBB-BIO/102863/2008 and doctoral grant SFRH/BD/84267/2012 awarded to S. Duarte). 
 
  
